Description

Latin America presents many opportunities for the infectious diseases market. This market insight offers an overview of the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well as drugs in clinical trial, is given for each disease type. Key statistics include the relative prevalence of each disease in Latin America. Conclusions and recommendations are also provided. The base year is 2012, with some timelines extending to 2018.